The effect of cefuroxime axetil on the faecal flora of healthy volunteers. 1990

D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
Department of Microbiology, Wycombe General Hospital, Bucks, UK.

The effect on the faecal flora of cefuroxime axetil, an oral ester of cefuroxime, was examined in ten healthy volunteers following a dose of 250 mg twice a day for 41/2 days. The mean blood concentration 2 h after the ninth dose was 3.6 mg/l and the urinary excretion was approximately 40% in 6 h and 50% in 24 h. Two volunteers developed mild diarrhoea and one candida vaginitis. Although there was variation between volunteers in the changes found in the faecal flora, the major effects were a reduction in the total anaerobic bacterial count, particularly where high levels of cefuroxime were present in the faeces and a significant decrease or elimination of strains of Enterobacteriaceae plus an increase in the streptococcal count. Six volunteers showed an increase in the candida count. Clostridium difficile was not isolated from any volunteer and toxin was not present in the two volunteers who developed diarrhoea. Four volunteers showed high levels of cefuroxime in the faeces on the fourth or fifth days of treatment.

UI MeSH Term Description Entries
D008297 Male Males
D002175 Candida A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH). Candida guilliermondii var. nitratophila,Candida utilis,Cyberlindnera jadinii,Hansenula jadinii,Lindnera jadinii,Monilia,Pichia jadinii,Saccharomyces jadinii,Torula utilis,Torulopsis utilis,Monilias
D002444 Cefuroxime Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS. Cephuroxime,Ketocef,Zinacef
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001420 Bacteria, Aerobic Bacteria which require oxygen in order to grow and survive. Aerobic Bacteria
D001421 Bacteria, Anaerobic Bacteria that can survive and grow in the complete, or nearly complete absence of oxygen. Anaerobic Bacteria
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
November 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
April 1986, European journal of clinical microbiology,
D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
October 1988, The Journal of antimicrobial chemotherapy,
D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
January 2013, Journal of clinical pharmacology,
D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
January 1985, Infection,
D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
January 2001, Mycoses,
D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
January 2012, Acta poloniae pharmaceutica,
D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
January 1997, Pharmacotherapy,
D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
January 1991, Scandinavian journal of infectious diseases,
D A Leigh, and B Walsh, and A Leung, and S Tait, and K Peatey, and P Hancock
December 1987, Pharmaceutisch weekblad. Scientific edition,
Copied contents to your clipboard!